New triple therapy for the diagnosis of CKD-MBD: a cross-sectional study in Shanxi province.

ABSTRACT:

Objectives

To seek a triple combination of biomarkers for early diagnosis of chronic kidney disease-mineral and bone metabolic disorder and to explore the diagnostic efficacy of β2-microglobulin, parathyroid hormone and blood urea nitrogen in chronic kidney disease-mineral and bone metabolic disorder.

Participants

We collected medical records of 864 patients with chronic kidney disease (without direct contact with patients) and divided them into two groups based on the renal bone disease manifestations of all patients.

Primary and secondary outcome measures

There were 148 and 716 subjects in the Chronic kidney disease-mineral and bone metabolic disorder and the control groups, respectively. The aggregated data included basic information and various clinical laboratory

SUBMITTER: Zhao Z 

PROVIDER: S-EPMC11331863 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature